(Q35987478)

English

Lipid-altering agents: the future

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

title

Lipid-altering agents: the future (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11 August 2017

A S Wierzbicki

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15605675

retrieved

11 August 2017

publication date

1 November 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15605675

retrieved

11 August 2017

published in

International Journal of Clinical Practice

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15605675

retrieved

11 August 2017

volume

58

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15605675

retrieved

11 August 2017

issue

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15605675

retrieved

11 August 2017

page(s)

1063-1072

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15605675

retrieved

11 August 2017

cites work

Systematic review on the risk and benefit of different cholesterol-lowering interventions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2004.00087.X

retrieved

21 January 2018

Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2004.00087.X

retrieved

21 January 2018

Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2004.00087.X

retrieved

21 January 2018

RETRACTED: Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.0400441101

Identifiers

DOI

10.1111/J.1742-1241.2004.00087.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15605675

retrieved

11 August 2017

PubMed publication ID

15605675

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15605675

retrieved

11 August 2017

(Q35987478)

Lipid-altering agents: the future

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)